| ADCs | Antibody–drug conjugates |
| ALI | Acute lung injury |
| ALK | Anaplastic lymphoma kinase |
| ARDS | Acute respiratory distress syndrome |
| ASM | Airway smooth muscle |
| ASMCs | Airway smooth muscle cells |
| BSMCs | Bronchial smooth muscle cells |
| CLP | Cecal ligation and puncture |
| COPD | Chronic obstructive pulmonary disease |
| CTGF | Connective tissue growth factor |
| CSE | Cigarette smoke extract |
| ECM | Extracellular matrix |
| ECs | Endothelial cells |
| EGFR | Epidermal growth factor receptor |
| EMT | Epithelial–mesenchymal transition |
| ERK | Extracellular-signal-regulated kinase |
| ET-1 | Endothelin-1 |
| FAK | Focal adhesion kinase |
| FAs | Focal adhesions |
| ILD | Interstitial lung disease |
| IPDI | Isophorone diisocyanate |
| IPF | Idiopathic pulmonary fibrosis |
| LPS | lipopolysaccharide |
| MAPK | Mitogen-activated protein kinase |
| NSCLC | Non-small cell lung cancer |
| OVA | Ovalbumin |
| PF | Pulmonary fibrosis |
| Poly (I:C) | Polyinosinic-polycytidylic acid |
| PTK2 | Protein tyrosine kinase 2 |
| Pyk2 | Proline-rich tyrosine kinase 2 |
| ROS | Reactive oxygen species |
| SCLC | Small cell lung cancer |
| TKIs | Tyrosine kinase inhibitors |
| EGFR-TKIs | Epidermal growth factor receptor tyrosine kinase inhibitor |
| TRALI | Transfusion-related acute lung injury |